News | October 13, 2014
  October 13, 2014 – Significant numbers of patients who have been treated with chemotherapy drugs are at risk to have...
Feature | October 10, 2014
October 10, 2014—Mitralign Inc. reported on the successful use of its technology to perform a percutaneous repair on a...
Feature | October 10, 2014
October 10, 2014 — Despite ongoing commercial challenges in 2013, the global medtech industry’s financial performance...
News | October 10, 2014
October 2, 2014 – A KLAS report revealed a lack of widespread integration with EMRs, continuing to limit the...
News | October 10, 2014
October 10, 2014 ­­­­– Direct Flow Medical Inc. has received the CE Mark for an enhanced transfemoral delivery system...
Feature | October 10, 2014
October 10, 2014 — The swift migration to cloud computing and data recovery services shows no signs of slowing, with...
LoneStar Heart Inc.Algisyl-LVR Hydrogel Implant Heart Failure Treatment CE Mark

LoneStar Heart Inc.Algisyl-LVR Hydrogel Implant Heart Failure Treatment CE Mark

News | October 10, 2014
October 10, 2014 — LoneStar Heart Inc. announced that it received the CE mark (Conformite Europeene) for its Algisyl-...
Preventice Three-in-one Switchability BodyGuardian Remote Monitoring System

Preventice Three-in-one Switchability BodyGuardian Remote Monitoring System

Technology | October 10, 2014
October 10, 2014 — Preventice Inc. announced improvements to its BodyGuardian Remote Monitoring System that have the...
News | October 09, 2014
October 9, 2014 — CardiacAssist Inc. announced that the first Protek Duo veno-venous extracorporeal life support (VV...
News | October 09, 2014
October 9, 2014 — Stanford Children’s Health is using cutting-edge videogame technology to get parents the information...
News | October 08, 2014
October 8, 2014 — At the recent Transcatheter Cardiovascular Therapeutics (TCT) meeting, representatives from Cardinal...
Feature | October 08, 2014
October 8, 2014 — New updates to the Society for Cardiovascular Angiography and Interventions (SCAI) appropriate use...
Feature | October 08, 2014
October 8, 2014 — Abbott announced the start of the ABSORB IV clinical trial, which will test whether the Absorb...
Feature | October 08, 2014
September 16, 2014 – Clinical trial results by Recover Right revealed a survival rate of 73 percent in the total...
Twelve-month Data St. Jude Medical EnligHTN Renal Denervation System
News | October 08, 2014
October 8, 2014 — St. Jude Medical Inc. announced 12-month outcome data from the EnligHTN III...
Overlay Init